TETRAPHASE PHARMACEUTICALS INC: cashflow_operating
| Value | {"amount": -18894000, "concept": "us-gaap:NetCashProvidedByUsedInOperatingActivities", "currency": "USD"} |
|---|---|
| Period | 2018-01-01 – 2018-03-31 |
| Status | current |
| Entity | TETRAPHASE PHARMACEUTICALS INC |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T13:11:20.304535+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/e963923c-ef26-4cf1-858d-66a2b377bb35
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001564590-19-017333 · Open the official SEC filing →Retrieved: 2026-08-19T13:11:20.304535+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001373707/cashflow-operating/2018-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/e963923c-ef26-4cf1-858d-66a2b377bb35
History
- supersedes {"amount": -18894000, "concept": "us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "currency": "USD"} (evidence 0001564590-18-010676)